Gyre Therapeutics (GYRE) Enterprise Value (2010 - 2026)
Gyre Therapeutics' Enterprise Value came in at $675.92 million for Q2 2026, up 3.9% from $650.56 million a year earlier and up 8.6% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Enterprise Value (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gyre Therapeutics reported Enterprise Value of $501.47 million, down 11.8% year-over-year; for FY2025, it came in at $577.13 million, down 45.2% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of 58.6% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $1.05 billion in FY2024 (-46.4%), $1.96 billion in FY2023, $28.01 million in FY2022 and -$18.32 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q1 2025.
- Year-over-year, Enterprise Value increased in 1 of the last seven quarters, with an average decline of 32.5%.
- Business Quant data shows GYRE's Enterprise Value at $622.49 million (Q1 2026), $577.13 million (Q4 2025) and $653.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 675.92 Mn |
| Mar 31, 2026 | 622.49 Mn |
| Dec 31, 2025 | 577.13 Mn |
| Sep 30, 2025 | 653.49 Mn |
| Jun 30, 2025 | 650.56 Mn |
| Mar 31, 2025 | 682.84 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.09 Bn |
| Jun 30, 2024 | 1.03 Bn |
| Mar 31, 2024 | 1.49 Bn |
| Dec 31, 2023 | 1.96 Bn |
| Sep 30, 2023 | 16.00 Mn |
| Jun 30, 2023 | 6.37 Mn |
| Mar 31, 2023 | -170,038.56 |
| Dec 31, 2022 | 28.01 Mn |
| Sep 30, 2022 | -7.35 Mn |
| Jun 30, 2022 | -19.37 Mn |
| Mar 31, 2022 | -14.04 Mn |
| Dec 31, 2021 | -18.32 Mn |
| Sep 30, 2021 | 64.48 Mn |
API Access
Gyre Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();